{"id":"mitomycin-for-injection","safety":{"commonSideEffects":[{"rate":null,"effect":"Myelosuppression (leukopenia, thrombocytopenia)"},{"rate":null,"effect":"Nausea and vomiting"},{"rate":null,"effect":"Hemolytic uremic syndrome"},{"rate":null,"effect":"Pulmonary toxicity"},{"rate":null,"effect":"Nephrotoxicity"}]},"_chembl":{"chemblId":"CHEMBL2108760","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Mitomycin is a naturally derived antibiotic that functions as a DNA-alkylating agent. After metabolic activation, it covalently binds to DNA and forms interstrand cross-links, which block DNA synthesis and repair mechanisms. This results in apoptosis and cell death, making it effective against rapidly dividing cancer cells.","oneSentence":"Mitomycin is an antibiotic that alkylates DNA, creating cross-links that prevent DNA replication and transcription, leading to cell death.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:50:02.647Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Gastric cancer"},{"name":"Colorectal cancer"},{"name":"Bladder cancer"},{"name":"Breast cancer"}]},"trialDetails":[{"nctId":"NCT07424287","phase":"PHASE3","title":"A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC","status":"NOT_YET_RECRUITING","sponsor":"Suzhou Suncadia Biopharmaceuticals Co., Ltd.","startDate":"2026-03","conditions":"NMIBC","enrollment":236},{"nctId":"NCT07358650","phase":"NA","title":"Clinical Study Evaluating the Safety and Performance of the MIST Device for Intraocular Pressure Reduction in Patients With Primary Open-Angle Glaucoma","status":"RECRUITING","sponsor":"Hexiris Inc","startDate":"2026-01-15","conditions":"Primary Open Angle Glaucoma","enrollment":25},{"nctId":"NCT06704191","phase":"PHASE1, PHASE2","title":"In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-04-21","conditions":"Non-Muscle Invasive Bladder Carcinoma, Stage 0a Bladder Cancer AJCC v8, Stage I Bladder Cancer AJCC v8","enrollment":40},{"nctId":"NCT05024734","phase":"PHASE2","title":"Guiding Instillation in Non Muscle-invasive Bladder Cancer Based on Drug Screens in Patient Derived Organoids","status":"RECRUITING","sponsor":"Roland Seiler-Blarer","startDate":"2023-02-21","conditions":"Bladder Cancer, Non-muscle Invasive","enrollment":34},{"nctId":"NCT06680245","phase":"PHASE3","title":"Effect of Mitomycin-C on the Outcomes of Patients Receiving Ahmed Glaucoma Valve Implantation Surgery","status":"NOT_YET_RECRUITING","sponsor":"St. Joseph's Healthcare Hamilton","startDate":"2024-12-01","conditions":"Glaucoma","enrollment":144},{"nctId":"NCT06232005","phase":"PHASE2, PHASE3","title":"Intralesional Injection of Mitomycin C Following Visual Internal Urethrotomy for Recurrent Urethral Stricture","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2022-01-01","conditions":"Urethral Stricture","enrollment":50},{"nctId":"NCT06227065","phase":"PHASE2","title":"Precise Neoadjuvant Chemoresection of Low Grade NMIBC","status":"NOT_YET_RECRUITING","sponsor":"University of Bern","startDate":"2024-10","conditions":"Bladder Cancer, Non-muscle Invasive Bladder Cancer, Low-risk","enrollment":28},{"nctId":"NCT03875911","phase":"PHASE4","title":"Comparing Preoperative Injection of Mitomycin-C vs. Intraoperative Injection of Mitomycin-C vs. Topical Application of Mitomycin-C (Conventional Use) in Trabeculectomy","status":"TERMINATED","sponsor":"University of California, Los Angeles","startDate":"2019-03-30","conditions":"Glaucoma Open-Angle Primary, Glaucoma, Open Angle Glaucoma","enrollment":19},{"nctId":"NCT03766425","phase":"EARLY_PHASE1","title":"Comparison of Efficacy and Safety of Mitomycin and Aflibercept Used to Support Primary Trabeculectomy.","status":"COMPLETED","sponsor":"Medical University of Lublin","startDate":"2017-06-14","conditions":"Eye Diseases, Optic Nerve Damage, Glaucoma Surgery","enrollment":64},{"nctId":"NCT05975151","phase":"PHASE2","title":"Efficacy and Safety of Pseudomonas Aeruginosa for Intermediate and High-risk Non-muscle Invasive Bladder Cancer","status":"UNKNOWN","sponsor":"Qilu Hospital of Shandong University","startDate":"2023-10-01","conditions":"Bladder Cancer","enrollment":63},{"nctId":"NCT02744690","phase":"NA","title":"Mitomycin C Trabeculectomy Trial for Glaucoma in Ethiopia","status":"WITHDRAWN","sponsor":"University of California, San Francisco","startDate":"2015-03-01","conditions":"Glaucoma","enrollment":""},{"nctId":"NCT04970251","phase":"NA","title":"Aflibercept as Adjunctive Treatment for Filtration Surgery in Neovascular Glaucoma","status":"COMPLETED","sponsor":"Siriraj Hospital","startDate":"2018-11-01","conditions":"Intraocular Pressure, Neovascular Glaucoma, Vascular Endothelial Growth Factor Overexpression","enrollment":5},{"nctId":"NCT01922154","phase":"PHASE4","title":"Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma","status":"COMPLETED","sponsor":"Siriraj Hospital","startDate":"2009-02","conditions":"Glaucoma, Neovascular","enrollment":15},{"nctId":"NCT03540953","phase":"NA","title":"Endoscopic Injection of Mitomycin C for the Treatment of Pharyngoesophageal Stenosis","status":"TERMINATED","sponsor":"Fauze Maluf Filho","startDate":"2015-01-05","conditions":"Esophageal Stenosis, Deglutition Disorders, Head and Neck Neoplasms","enrollment":12},{"nctId":"NCT02471495","phase":"PHASE3","title":"RITE-EUROPE (Radiofrequency-Induced Thermochemotherapy Effect-EUROPE)","status":"WITHDRAWN","sponsor":"Medical Enterprises Europe B.V.","startDate":"2016-09","conditions":"Bladder Cancer","enrollment":""},{"nctId":"NCT00626782","phase":"PHASE2, PHASE3","title":"Lucentis Versus Mitomycin C During Glaucoma Surgery","status":"COMPLETED","sponsor":"Wills Eye","startDate":"2008-01","conditions":"Glaucoma","enrollment":24},{"nctId":"NCT02406833","phase":"PHASE1","title":"Phase I Dose Escalation Study to Investigate the Safety of ISTH0036 in Subjects With Glaucoma Undergoing Trabeculectomy","status":"COMPLETED","sponsor":"Isarna Therapeutics GmbH","startDate":"2015-04","conditions":"Primary Open Angle Glaucoma","enrollment":13},{"nctId":"NCT01200992","phase":"PHASE3","title":"Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer","status":"TERMINATED","sponsor":"Bioniche Life Sciences Inc.","startDate":"2010-11","conditions":"Bladder Neoplasm, Neoplasm Recurrence, Local, Transitional Cell, Carcinoma","enrollment":84},{"nctId":"NCT02901236","phase":"PHASE2, PHASE3","title":"Bevacizumab Versus Mitomycin C as Trabeculectomy Adjuvant in Uncontrolled Glaucoma","status":"COMPLETED","sponsor":"Athens Vision Eye Institute","startDate":"2014-01","conditions":"Glaucoma","enrollment":40},{"nctId":"NCT02301091","phase":"PHASE3","title":"Combine TACE and RFA Versus TACE Alone for HCC With PVTT","status":"UNKNOWN","sponsor":"Ming Zhao","startDate":"2014-10","conditions":"Hepatocellular Carcinoma","enrollment":240},{"nctId":"NCT02638857","phase":"PHASE1, PHASE2","title":"Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma","status":"UNKNOWN","sponsor":"Second Military Medical University","startDate":"2015-09","conditions":"Recurrence Hepatocellular Carcinoma, Advanced Hepatocellular Carcinoma","enrollment":60},{"nctId":"NCT00357474","phase":"PHASE3","title":"Comparison Study of Transarterial Chemoembolization and Percutaneous Ethanol Injection for Multiple, Small HCCs","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2005-10","conditions":"Hepatocellular Carcinoma","enrollment":22},{"nctId":"NCT01489566","phase":"PHASE3","title":"Study of Tyroserleutide for Injection in Hepatocellular Carcinoma (HCC) Patients","status":"UNKNOWN","sponsor":"Shenzhen Kangzhe Pharmaceutical Co., Ltd.","startDate":"2011-07","conditions":"Hepatocellular,Carcinoma","enrollment":300},{"nctId":"NCT00854529","phase":"PHASE2","title":"Subconjunctival Bevacizumab Effect on Bleb Vascularity","status":"UNKNOWN","sponsor":"Rabin Medical Center","startDate":"2009-04","conditions":"Bleb Vascularity, Bleb Fibrosis, Trabeculectomy Failure","enrollment":60},{"nctId":"NCT00644215","phase":"NA","title":"Comparison of Subconjunctival 5-Fluorouracil (FU) Injection and Mitomycin C for Treatment of Early Bleb Failure","status":"UNKNOWN","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2007-06","conditions":"Bleb","enrollment":40},{"nctId":"NCT00644020","phase":"","title":"Phase ⅡStudy of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) Patients","status":"UNKNOWN","sponsor":"Shenzhen Kangzhe Pharmaceutical Co., Ltd.","startDate":"2007-12","conditions":"Hepatocellular Carcinoma","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":8,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Mitomycin for Injection","genericName":"Mitomycin for Injection","companyName":"Suzhou Suncadia Biopharmaceuticals Co., Ltd.","companyId":"suzhou-suncadia-biopharmaceuticals-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Mitomycin is an antibiotic that alkylates DNA, creating cross-links that prevent DNA replication and transcription, leading to cell death. Used for Gastric cancer, Colorectal cancer, Bladder cancer.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}